Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
J Urol. 2011 Mar;185(3):795-801. doi: 10.1016/j.juro.2010.10.068. Epub 2011 Jan 15.
Renal oncocytosis is a rare pathological condition in which renal parenchyma is diffusely involved by numerous oncocytic nodules in addition to showing a spectrum of other oncocytic changes. We describe our experience with renal oncocytosis, focusing on management and outcomes.
A total of 20 patients with a final pathological diagnosis of renal oncocytosis from July 1995 through June 2009 were included in the analysis. Patient demographics, intraoperative variables and postoperative outcomes are reported.
Median age at nephrectomy was 71 years (IQR 59-75). Of the patients 15 (75%) had bilateral disease. There were 23 operations (9 right side, 14 left side) performed on 20 patients, and of these procedures 13 (57%) were partial nephrectomies and 10 (43%) were radical nephrectomies. Median dominant tumor mass diameter was 4.1 cm (IQR 3-6.4, range 1 to 14.6). The most common dominant tumor histology was hybrid tumor between oncocytoma and chromophobe renal cell carcinoma in 13 of 23 specimens (57%), followed by chromophobe renal cell carcinoma in 6 (26%), oncocytoma in 3 (13%) and conventional renal cell carcinoma in 1 (4%). Ten patients (50%) had preexisting chronic kidney disease before nephrectomy and chronic kidney disease developed in 5 more after surgery. After a median followup of 35 months no patients had metastatic disease.
Patients with renal oncocytosis usually present with multiple and bilateral renal nodules. Half of the patients had chronic kidney disease at diagnosis and 25% had new onset of chronic kidney disease. No patient had distant metastatic disease during followup. Our management approach is to perform partial nephrectomy when possible and then use careful surveillance of the remaining renal masses.
肾嗜酸细胞瘤是一种罕见的病理状况,除了表现出一系列其他嗜酸细胞变化外,肾实质还广泛受累于许多嗜酸细胞瘤结节。我们描述了我们在肾嗜酸细胞瘤方面的经验,重点是管理和结果。
总共分析了 20 名 1995 年 7 月至 2009 年 6 月最终病理诊断为肾嗜酸细胞瘤的患者。报告了患者的人口统计学资料、术中变量和术后结果。
肾切除术时的中位年龄为 71 岁(IQR 59-75)。15 名患者(75%)患有双侧疾病。对 20 名患者进行了 23 次手术(9 次右侧,14 次左侧),其中 13 次(57%)为部分肾切除术,10 次(43%)为根治性肾切除术。中位优势肿瘤肿块直径为 4.1cm(IQR 3-6.4,范围 1-14.6)。23 个标本中最常见的优势肿瘤组织学是 13 个(57%)嗜酸细胞瘤和嫌色细胞肾细胞癌的混合肿瘤,其次是 6 个(26%)嫌色细胞肾细胞癌、3 个(13%)嗜酸细胞瘤和 1 个(4%)传统肾细胞癌。10 名患者(50%)在肾切除术之前有预先存在的慢性肾脏病,5 名患者在手术后出现新的慢性肾脏病。中位随访 35 个月后,没有患者发生转移性疾病。
肾嗜酸细胞瘤患者通常表现为多发性和双侧肾结节。一半的患者在诊断时患有慢性肾脏病,25%的患者在手术后出现新的慢性肾脏病。在随访期间,没有患者发生远处转移疾病。我们的管理方法是在可能的情况下进行部分肾切除术,然后仔细监测剩余的肾肿块。